Role of direct oral anticoagulant in the treatment of Deep vein thrombosis
Direct oral anticoagulants (DOACs) have been increasingly used in the treatment of deep vein thrombosis (DVT) due to their efficacy, convenience, and safety profile compared to traditional anticoagulants like warfarin. DOACs are a type of anticoagulant medication that directly inhibits specific blood clotting factors. Some of the DOACs used in the treatment of DVT include dabigatran, rivaroxaban, apixaban ( Eliquis 5mg tablet ), and edoxaban. Role of DOACs in the Treatment of Deep Vein Thrombosis: Effective Anticoagulation: It inhibits specific clotting factors, such as factor Xa or thrombin, to prevent the formation of blood clots. Oral Administration: One significant advantage of DOACs is that they are administered orally. This eliminates the need for frequent monitoring of blood clotting parameters, as is required with warfarin, making DOACs more convenient for both patients and healthcare providers. Reduced Risk of Bleeding: DOACs are used to reduce the risk of major bl...